Torrent Pharmaceuticals experienced a decline in today's session, with its shares decreasing by 1.95% to Rs 3341.70. The decrease was accompanied by high trading volumes, suggesting significant market activity.
The stock is part of the NIFTY NEXT 50 index, making its performance relevant to investors tracking this index. According to Moneycontrol analysis, the sentiment for Torrent Pharmaceuticals was neutral as of June 25, 2025.
Financial Performance
Torrent Pharmaceuticals' financial performance shows a consistent trend in revenue and net profit growth over the past few years. The following data provides a snapshot of the company's consolidated financials.
Revenue
The company's revenue has shown steady growth over the last five years:
Mar 2025: Rs 11,516.00 Cr
Mar 2024: Rs 10,727.84 Cr
Mar 2023: Rs 9,620.15 Cr
Mar 2022: Rs 8,508.04 Cr
Mar 2021: Rs 8,004.57 Cr
Net Profit
Net profit has also increased consistently:
Mar 2025: Rs 1,911.00 Cr
Mar 2024: Rs 1,656.38 Cr
Mar 2023: Rs 1,245.23 Cr
Mar 2022: Rs 777.18 Cr
Mar 2021: Rs 1,251.88 Cr
Earnings Per Share (EPS)
The EPS figures are as follows:
Mar 2025: Rs 56.47
Mar 2024: Rs 48.94
Mar 2023: Rs 36.79
Mar 2022: Rs 45.93
Mar 2021: Rs 73.98
Quarterly Performance
A look at the recent quarterly performance reveals:
Mar 2025: Revenue of Rs 2,959.00 Cr and Net Profit of Rs 498.00 Cr
Dec 2024: Revenue of Rs 2,809.00 Cr and Net Profit of Rs 503.00 Cr
Sep 2024: Revenue of Rs 2,889.00 Cr and Net Profit of Rs 453.00 Cr
Jun 2024: Revenue of Rs 2,859.00 Cr and Net Profit of Rs 457.00 Cr
Mar 2024: Revenue of Rs 2,745.00 Cr and Net Profit of Rs 449.00 Cr
Additional Financial Ratios
Key financial ratios provide further insight into the company's performance:
Book Value Per Share (Mar 2025): Rs 224.59
Return on Equity (Mar 2025): 25.17%
Debt to Equity Ratio (Mar 2025): 0.40
Balance Sheet Snapshot
The consolidated balance sheet shows the following trends:
Share Capital (Mar 2025): Rs 169 Cr
Reserves & Surplus (Mar 2025): Rs 7,422 Cr
Total Assets (Mar 2025): Rs 14,990 Cr
The cash flow statement indicates the following:
Net Cash Flow (Mar 2025): -Rs 262 Cr
In summary, Torrent Pharmaceuticals' stock is currently trading at Rs 3341.70, reflecting a 1.95% decrease.
